COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will announce the ...
FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was ...
Andrea Brault is fighting acute myeloid leukemia and needs a bone marrow transplant. But finding a donor match can be more ...
When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer ...
A chromosome is a package of DNA that exists inside the nucleus of a cell. A karyotype refers to the unique collection of chromosomes present in a person’s cells. Acute myeloid leukemia (AML) is a ...
Liver transplant rejection significantly affects patient prognosis. Myeloid-derived suppressor cells (MDSCs), known for their ...
6d
LTZ Therapeutics Raises $38 Million in Support of Advancing Myeloid Engager Immunotherapy Pipeline
LTZ announces $38 million financing to advance development of immunotherapy pipeline targeting oncology and autoimmune ...
Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...
The review highlights current strategies for myeloid cell targeting and novel agents targeting myeloid cells for cancer treatment. Myeloid cells are innate immune cells, and they include macrophages, ...
Modern acute myeloid leukemia care is rapidly evolving, with the approval of multiple novel agents during the past 5 years. Therapeutic decision-making is guided by integrating patient-related and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results